
Celeste A. Roney
Examiner (ID: 19047, Phone: (571)272-5192 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612 |
| Total Applications | 873 |
| Issued Applications | 472 |
| Pending Applications | 148 |
| Abandoned Applications | 293 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18535339
[patent_doc_number] => 20230240421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => PROCESS FOR PERMANENT WAVING KERATIN FIBERS
[patent_app_type] => utility
[patent_app_number] => 18/004574
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6873
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 253
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004574
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004574 | PROCESS FOR PERMANENT WAVING KERATIN FIBERS | Jul 6, 2021 | Pending |
Array
(
[id] => 17168761
[patent_doc_number] => 20210322431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/359414
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21463
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17359414
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/359414 | Corticotropin releasing factor receptor antagonists | Jun 24, 2021 | Issued |
Array
(
[id] => 17168760
[patent_doc_number] => 20210322430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/359411
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21479
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17359411
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/359411 | Corticotropin releasing factor receptor antagonists | Jun 24, 2021 | Issued |
Array
(
[id] => 17154877
[patent_doc_number] => 20210315928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => SYNERGISTIC COMPOSITION OF VITAMIN C AND VITAMIN K1, AND COMPOSITIONS THEREOF FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/357651
[patent_app_country] => US
[patent_app_date] => 2021-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17357651
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/357651 | SYNERGISTIC COMPOSITION OF VITAMIN C AND VITAMIN K1, AND COMPOSITIONS THEREOF FOR THE TREATMENT OF CANCER | Jun 23, 2021 | Abandoned |
Array
(
[id] => 18656182
[patent_doc_number] => 20230302061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS USING FOURNIERELLA MASSILIENSIS
[patent_app_type] => utility
[patent_app_number] => 18/009604
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -113
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009604
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009604 | COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS USING FOURNIERELLA MASSILIENSIS | Jun 10, 2021 | Abandoned |
Array
(
[id] => 17110388
[patent_doc_number] => 20210290985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => CORE STABILIZED MICROCAPSULES, METHOD OF THEIR PREPARATION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/340334
[patent_app_country] => US
[patent_app_date] => 2021-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9444
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17340334
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/340334 | Core stabilized microcapsules, method of their preparation and uses thereof | Jun 6, 2021 | Issued |
Array
(
[id] => 20246715
[patent_doc_number] => 20250295584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-25
[patent_title] => Dynamically crosslinked injectable hydrogels with chemically stabilized multilamellar vesicles
[patent_app_type] => utility
[patent_app_number] => 17/928058
[patent_app_country] => US
[patent_app_date] => 2021-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17928058
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/928058 | Dynamically crosslinked injectable hydrogels with chemically stabilized multilamellar vesicles | Jun 6, 2021 | Pending |
Array
(
[id] => 18063885
[patent_doc_number] => 20220394972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => TERMITE REPELLANT AND WOOD PROTECTOR
[patent_app_type] => utility
[patent_app_number] => 17/338658
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14222
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17338658
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/338658 | Termite repellant and wood protector | Jun 2, 2021 | Issued |
Array
(
[id] => 17065681
[patent_doc_number] => 20210267896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => FORMULATIONS FOR TREATING BLADDER CANCER
[patent_app_type] => utility
[patent_app_number] => 17/324584
[patent_app_country] => US
[patent_app_date] => 2021-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9254
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17324584
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/324584 | FORMULATIONS FOR TREATING BLADDER CANCER | May 18, 2021 | Abandoned |
Array
(
[id] => 18482831
[patent_doc_number] => 20230210116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => HONEYBEE REPELLENT
[patent_app_type] => utility
[patent_app_number] => 17/999038
[patent_app_country] => US
[patent_app_date] => 2021-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999038
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999038 | HONEYBEE REPELLENT | May 17, 2021 | Abandoned |
Array
(
[id] => 19246781
[patent_doc_number] => 20240197765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => Antiviral compositions comprising liposome-encapsulated ascorbyl glucoside and natural extracts
[patent_app_type] => utility
[patent_app_number] => 18/556171
[patent_app_country] => US
[patent_app_date] => 2021-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4868
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18556171
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/556171 | Antiviral compositions comprising liposome-encapsulated ascorbyl glucoside and natural extracts | May 12, 2021 | Pending |
Array
(
[id] => 18737807
[patent_doc_number] => 20230346703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => Myelin Nanovesicles And Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/925262
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6614
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17925262
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/925262 | Myelin Nanovesicles And Uses Thereof | May 11, 2021 | Pending |
Array
(
[id] => 17314362
[patent_doc_number] => 20210403410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => OPHTHALMIC FORMULATION
[patent_app_type] => utility
[patent_app_number] => 17/318581
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17318581
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/318581 | OPHTHALMIC FORMULATION | May 11, 2021 | Abandoned |
Array
(
[id] => 19316902
[patent_doc_number] => 20240238442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => LIPOSOMES DISPLAYING A GLYCAN LIGAND FOR CD33 AND THEIR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/558999
[patent_app_country] => US
[patent_app_date] => 2021-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11659
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18558999
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/558999 | LIPOSOMES DISPLAYING A GLYCAN LIGAND FOR CD33 AND THEIR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE | May 4, 2021 | Pending |
Array
(
[id] => 17198529
[patent_doc_number] => 20210338623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => COMPOSITIONS COMPRISING N-ACETYL METHYL GABA AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 17/245861
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11979
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17245861
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/245861 | Compositions comprising N-acetyl methyl GABA and related methods | Apr 29, 2021 | Issued |
Array
(
[id] => 17034802
[patent_doc_number] => 20210251760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => Reinforced Bone Scaffold
[patent_app_type] => utility
[patent_app_number] => 17/240562
[patent_app_country] => US
[patent_app_date] => 2021-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6933
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17240562
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/240562 | Reinforced bone scaffold | Apr 25, 2021 | Issued |
Array
(
[id] => 18374491
[patent_doc_number] => 20230149570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => METAL NUCLIDE-LOADED CARBON MICROSPHERE (CMS), PREPARATION METHOD, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/916091
[patent_app_country] => US
[patent_app_date] => 2021-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916091
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/916091 | Metal nuclide-loaded carbon microsphere (CMS), preparation method, and use thereof | Apr 22, 2021 | Issued |
Array
(
[id] => 17206558
[patent_doc_number] => 11166909
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-11-09
[patent_title] => Liposomal nanoparticle essential oil composition for nostril administration
[patent_app_type] => utility
[patent_app_number] => 17/234863
[patent_app_country] => US
[patent_app_date] => 2021-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 9260
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17234863
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/234863 | Liposomal nanoparticle essential oil composition for nostril administration | Apr 19, 2021 | Issued |
Array
(
[id] => 19246993
[patent_doc_number] => 20240197977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => IMPROVED IMMUNE RESPONSE AND DECREASED IMMUNOPARALYSIS WITH IMMUNOMODULATING TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/919053
[patent_app_country] => US
[patent_app_date] => 2021-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -75
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17919053
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/919053 | IMPROVED IMMUNE RESPONSE AND DECREASED IMMUNOPARALYSIS WITH IMMUNOMODULATING TREATMENT | Apr 13, 2021 | Pending |
Array
(
[id] => 18909349
[patent_doc_number] => 11872312
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-16
[patent_title] => Neuroprotective liposome compositions and methods for treatment of stroke
[patent_app_type] => utility
[patent_app_number] => 17/229627
[patent_app_country] => US
[patent_app_date] => 2021-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12649
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17229627
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/229627 | Neuroprotective liposome compositions and methods for treatment of stroke | Apr 12, 2021 | Issued |